Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Enzymatica AB: ColdZyme cold spray reduces sickness absence among preschool staff

NewsLund 17 October 2017 ColdZyme cold spray reduces sickness absence among preschool staff Enzymatica has evaluated ColdZyme® Mouth Spray against common cold, for colds among preschool staff during the cold season. The results show that the use of ColdZyme reduced sickness absence by more than three days, from 7.4 to 4.1 days. In cases where the staff in the study did catch a cold, the symptoms of infection were less severe. Enzymatica conducted an observation study with 15 subjects whom used ColdZyme to prevent colds during "the common cold season" (October-March). The 15

Invitation to UPM's press conference and webcast on Interim Results for the third quarter of 2017

(UPM, Helsinki, 17 October 2017 at 10:00 EET) - UPM will publish its third quarter 2017 results on 24 October 2017 at 09:30-10:00 EET. The report will be available on the company's website at www.upm.com  after publishing. UPM's President and CEO Jussi Pesonen will present the financial results in a webcast and a conference call for analysts and investors, held in English language, on 24 October 2017 at 13:15 EET. Later in the afternoon, Jussi Pesonen will present the results in a press conference held in Finnish language at the UPM Group Head

INVITATION: Finnair Q3 2017 result – Press conference, analyst briefing and webcast

Finnair will hold a result press conference on 25 October 2017 at 11:00 a.m. and an analyst briefing at 12:30 p.m. at its office at Tietotie 9. An English-language telephone conference and webcast will begin at 2:30 p.m. Finnish time. The conference may be attended by dialling your local access number 09 7479 0361 (Finland), 0200 880 389 (Sweden), 0800 358 6377 (UK) or +44 (0)330 336 9105 (all other countries). The confirmation code is 2226645. To join the live webcast, please register at: https://slideassist.webcasts.com/starthere.jsp?ei=1163618 

Inwido AB’s Nomination Committee for the 2018 Annual General Meeting

Based on the ownership structure as of September 2017 the three largest shareholders in Inwido AB (publ) in terms of voting rights were consulted and expressed their desire to participate in the nomination process. The Nomination Committee has been appointed by the Fourth AP Fund, Handelsbanken and Swedbank Robur Fund. Each has appointed a representative, as detailed below, who, together with the Chairman of the board, constitute Inwido’s Nomination Committee.Members of the Nomination Committee elected by the three largest shareholders:Thomas Wuolikainen, Fourth AP Fund (Chairman of the

Seamless considers re-alignment for sustainable growth

The Board of Seamless Distribution today announces that it considers to present proposals in two areas that are intended to accelerate profitable growth, and focus on activities with the highest probability of success. The proposals that are up for considerations are the following: 1. Phasing out of the B2C offering SEQR, and a renewed focus on B2B offerings, where traction is both strong and accelerating. Phasing out the B2C offering SEQR would preferably be made in the form of a sale or winding-down. 2. To fund the growth of B2B, and exit costs of B2C, the Board considers to

Martin N Larsson leaves Seamless

Martin N Larsson, Head of Treasury and Investor Relations, has decided to leave Seamless. - Martin has made important contributions to Seamless despite his short time with the company. I am very grateful for Martin's efforts and wish him good luck in the future, "says Tomas Jalling, CEO of Seamless. Martin Schedin, CFO, will assume the responsibilities investor relations. For further information, please contact:Martin Schedin, CFO, martin.schedin@seamless.se, +46 8 564 878 00 This information is information that Seamless Distribution AB (publ) is obliged to make public

NOTE’s Interim Report January–September 2017

Financial performance July–September• Sales increased by 7% to SEK 265.2 (248.4) million.• Operating profit rose to SEK 20.1 (14.1) million.• Operating margin expanded by 1.9 percentage points to 7.6% (5.7%).• Profit after financial items increased to SEK 18.8 (12.9) million.• Profit after tax rose to SEK 15.8 (11.1) million, corresponding to SEK 0.55 (0.38) per share.• Cash flow after investments amounted to SEK -11.2 (6.5) million, or SEK -0.39 (0.23) per share.Financial performance January–September• Sales amounted to SEK 850.7 (809.9) million. Excluding divestments,

Interim Management Statement January-September 2017

Highlights during the third quarter · Adjusted net asset value*, based on estimated market values for the major wholly-owned subsidiaries and partner-owned investments within Patricia Industries, amounted to SEK 380,140 m. (SEK 497 per share) on September 30, 2017, an increase of SEK 3,404 m., or 1 percent, during the quarter. · Reported net asset value1)* amounted to SEK 335,581 m. (SEK 439 per share) on September 30, 2017, an increase of SEK 4,343 m. (SEK 6 per share), or 1 percent, during the quarter. · Listed Core Investments generated a total return* of 2 percent. Shares in

Nexam Chemical supplies material for semiconductors – new segment within the high performance focus area

Nexam Chemical will early next year start supplying material to a new Japanese customer within the focus area high performance polymers, and thereby opening a new high performance segment – solutions for semiconductors.The customer, a leading Japanese manufacturer of semiconductor materials, has for a long time collaborated with Nexam Chemical to produce materials that meet the high standards of semiconductor encapsulation materials. Semiconductors are included in the components of most of the electronics we currently have around us, e.g. mobile phones, computers etc. As components become

Invitation to the presentation of Resurs’s third quarter report 2017

Resurs’s report for the third quarter 2017 will be published at 07.30 CET on October 31. Resurs’s CEO Kenneth Nilsson and CFO Peter Rosén will host a presentation starting at 9.00 CET. The presentation will be followed by a Q&A session.The presentation will be held at GT30, Grev Turegatan 30 in Stockholm. Coffee will be served from 08.45 CET. For participation at the event, please register in advance through following link: http://www.financialhearings.com/event/9884/register/live_event  The presentation will be held in Swedish and can be followed on the web or over the phone. The

Notice to annual general meeting in Internationella Engelska Skolan i Sverige Holdings II AB (publ)

The shareholders in Internationella Engelska Skolan i Sverige Holdings II AB (publ) are hereby summoned to an annual general meeting to be held on 17 november 2017 at 16.00 at the premises of Internationella Engelska Skolan in Kista, Isafjordsgatan 39, Kista. Notification, etc.Shareholders who wish to participate at the meeting must: firstly be included in the shareholders’ register maintained by Euroclear Sweden AB as of Friday 10 November 2017 (record date Saturday 11 November 2017) ; and secondly notify the company of their participation in the meeting no later than Monday 13

FDA accepts sBLA file for Imfinzi; priority review

17 October 2017 07:00 BST US FDA ACCEPTS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR IMFINZI IN LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER Imfinzi granted Priority Review Acceptance follows FDA's Breakthrough Therapy Designation AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab) for the treatment of patients with locally advanced (Stage III) unresectable non-small cell lung cancer (

Tieto joins ServiceNow Services, Sales and Technology Partner Program

Tieto has joined the ServiceNow Services, Sales and Technology Partner Programs to help modernise and transform service delivery for customers across the Nordic countries. Bringing together Tieto’s Nordic industry expertise and full lifecycle service capabilities with the ServiceNow platform will provide customers with a robust and strategic way of managing services in a multi-supplier ecosystem, enabling organisations to improve their performance and quality of service.Many Nordic enterprises and organizations currently operate in an environment with multiple IT and service suppliers

SaltX Technology introduces SunCool in Ghana

- Starts cooperation with a local energy company Nasdaq First North-listed SaltX Technology has initiated collaboration with a newly established energy company in Ghana - SolarX. In connection with the agreement, the company has placed a first order of a solar demonstration kit to be displayed to authorities and potential customers. The demonstration platform will be installed at the university in Accra where SolarX will provide training for installers and franchisees of the concept in all of the country's districts.As a part of the marketing of SunCool in Africa, SaltX has recently

Peikko delivers connection items to the world’s largest aluminium smelter plant in Bahrain

Peikko Group’s subsidiary in The Kingdom of Saudi Arabia, Al Rashed Peikko LLC, has received a substantial order of connection items to an expansion of an aluminium smelter plant located in Bahrain. The order comprises more than 10 000 pieces of HPKM® Column Shoes and HPM® Rebar Anchor Bolts for the plant’s column connections. The deliveries are ongoing and they will continue until the end of 2017. The new pot line is estimated to begin production in early 2019. The developer of the plant is Aluminium Bahrain (ALBA), and the main contractor is Nass Contracting. Bechtel

Reservoir Link and Archer alliance yields contract award for ROC Oil

Kuala Lumpur, Malaysia, 10/17/2017  Reservoir Link , the well intervention and perforating solutions provider, has been awarded a contract to deliver annulus wash and cementing assurance (AWCA) equipment and services with Archer , the global oilfield services company, to ROC Oil (Sarawak) Sdn Bhd (“ROC Oil”) in Southeast Asia. The project, which is estimated to commence in Q4 2017, will see the companies provide equipment and

PONSSE’S INTERIM REPORT FOR 1 JANUARY – 30 SEPTEMBER 2017

PONSSE PLC, STOCK EXCHANGE RELEASE, 17 OCTOBER 2017, 9:00 a.m.PONSSE’S INTERIM REPORT FOR 1 JANUARY – 30 SEPTEMBER 2017– Net sales amounted to EUR 398.3 (Q1-Q3/2016 349,9) million.– Q3 net sales amounted to EUR 139.6 (Q3/2016 112,7) million.– Operating result totalled EUR 46.8 (Q1-Q3/2016 37,0) million, equalling 11.8 (10.6) per cent of net sales.– Q3 operating result totalled EUR 18.6 (Q3/2016 10,8) million, equalling 13.3 (9.6) per cent of net sales.– Profit before taxes was EUR 40.4 (Q1-Q3/2016 38,5) million.– Cash flow from business operations was EUR 20.7 (14.9) million.

Invitation to presentation of Bravida’s report for the third quarter 2017 on the 10th of November

Bravida’s report for the third quarter 2017 will be published 07:30 CET on the 10th of November.The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Nils-Johan Andersson. The presentation will be held in English and can be followed on the web or over the phone. There will be room for questions. Link to the webcast:https://tv.streamfabriken.com/bravida-q3-2017 Telephone numbers for telephone conference:SE: +46 8 5664 2690UK: +44 20 3008 9807US: +1 85 5831 5947 The report and the presentation will be available on www.bravida.se/en/

Nudging makes us eat more vegetarian food

The way we eat has a big impact on the environment.  New research by the School of Business, Economics and Law at the University of Gothenburg shows how simple methods can influence restaurant diners to reduce their meat consumption in favour of vegetarian food, resulting in reduced greenhouse gas emissions.“The preference for meat is not as strong and stable as many people think and we should not assume that we will eat as much meat as we do today. What we choose to buy is decided not only by price and availability but also by the environment around the decision. My research shows that it

Good demand and stable results

CEO Per Lindberg comments on the development during Q3 2017: “We experienced a very strong market in the quarter, resulting in positive sales performance. Net sales were up 3% and volumes were up 1% on last year. Overall, we have had some difficulties with production availability in recent quarters, so we have established a new organisation to work proactively on both availability and quality at our facilities. I am confident that this will generate results over the coming years. Looking ahead, market conditions appear encouraging, and we see good opportunities for continued growth.

INTERIM REPORT January–September 2017

(Tables included in attached PDF)Q3 2017 · Net sales SEK 5 544 m · EBITDA SEK 1 051 m · EBITDA margin 19% · Earnings per share SEK 2.48 KEY HIGHLIGHTS · Net sales for the third quarter increased by approximately 3% compared with the same quarter last year, mainly as a result of improved prices in local currency. · EBITDA was just over 1% better than in the same quarter last year as a result of local price increases. · EBITDA was affected by costs of SEK 215 million for planned maintenance shutdowns. · Earnings per share for the quarter amounted to SEK 2.48 (2.

NattoPharma & Ortho Molecular Products Form Exclusive Partnership

MenaQ7® PRO will only be available to the Practitioner Channel via Ortho Molecular ProductsOSLO, NORWAY and METUCHEN, NJ (October 17, 2017) – Nattopharma is pleased to announce that it has been selected by Ortho Molecular Products, the leader in practitioner-specific nutraceuticals, as its exclusive Vitamin K2 supplier partner. The company will transition the seven products in its line currently featuring Vitamin K2 to MenaQ7® PRO, a unique line extension available only to Ortho Molecular. For more than 25 years, Ortho Molecular Products has researched and manufactured high-quality,

Multiconsult ASA – Repurchase of own shares

On 16 October 2017, Multiconsult ASA ("Multiconsult") purchased 8 500 of its own shares at an average price of NOK 87.00 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 77 481 of its own shares. For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

Collector Ventures invests as Gimi closes round of 29 Million SEK

Several of Sweden’s leading tech investors participated as Gimi closed its latest venture round of 29 Million SEK. Among those who invested are Lena Apler via Collector Ventures and EA boss Patrick Söderlund.Gimi is the company behind the app, which in Sweden operates under the name Veckopengen, one of Europe’s fastest growing fintech apps. Gimi enables young people to earn, save and spend their own money. For parents it is a smart way to teach their children about money and support their financial future. Over the last year the company has grown from 100 000 to over 400 000 users. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top